Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

elanco australasia pty ltd - yohimbine hydrochloride - parenteral liquid/solution/suspension - yohimbine hydrochloride alkaloid active 10.0 mg/ml - antidotes - cattle | deer | beef | bos indicus | bos taurus | bovine | buffalo | bull | bullock | calf | cow | dairy cow | doe | fallow deer - reversal of xylazine based sedation

European Union - English - EMA (European Medicines Agency)

orion corporation - dexmedetomidine hydrochloride - conscious sedation - psycholeptics - for sedation of adult intensive care unit patients requiring a sedation level not deeper than arousal in response to verbal stimulation (corresponding to richmond agitation-sedation scale (rass) 0 to -3).

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

apvma permit - benzocaine(1000mg/g) - anaesthetic-local

Singapore - English - HSA (Health Sciences Authority)

radiance medical systems - anaesthesiology - the device is intended for continuous monitoring of brain activity index (ai), the main parameter defined by the device, calculated by analyzing patient’s electroencephalogram (eeg) in the time and frequency domains. also it defines optional parameters: eeg signal suppression rate (sr); eeg signal quality index (sqi); electromyographic component level (emg). the device is intended for assessment and long-term monitoring of patient‘s depth of anaesthesia and sedation: in medical institutions, operating rooms, anesthesiology departments and groups, resuscitations and intensive care departments for adults and children; specialized departments rooms; anesthesiology and resuscitation centers; in intraoperative, preoperative, preparatory and postoperative period; during invasive diagnostic interventions and intensive therapy at anesthetic sedative exposure.

European Union - English - EMA (European Medicines Agency)

paion deutschland gmbh - remimazolam besilate - conscious sedation - psycholeptics - remimazolam is indicated in adults for procedural sedation.remimazolam 50 mg is indicated in adults for intravenous induction and maintenance of general anaesthesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - remifentanil hydrochloride, quantity: 2.194 mg (equivalent: remifentanil, qty mg) - injection, powder for - excipient ingredients: hydrochloric acid; glycine - remifentanil is indicated:,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures but not cardiac procedures in children aged 1 to 12 years,? for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery,when endotracheal intubation and controlled ventilation are anticipated.,? for provision of analgesia and sedation in mechanically ventilated intensive care patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - remifentanil hydrochloride, quantity: 5.485 mg (equivalent: remifentanil, qty mg) - injection, powder for - excipient ingredients: hydrochloric acid; glycine - remifentanil is indicated:,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures but not cardiac procedures in children aged 1 to 12 years,? for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery,when endotracheal intubation and controlled ventilation are anticipated.,? for provision of analgesia and sedation in mechanically ventilated intensive care patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - remifentanil hydrochloride, quantity: 1.097 mg (equivalent: remifentanil, qty mg) - injection, powder for - excipient ingredients: hydrochloric acid; glycine - remifentanil is indicated:,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures including cardiac surgery in adults,? as an opioid adjunct for use during induction and/or maintenance of general anaesthesia during surgical procedures but not cardiac procedures in children aged 1 to 12 years,? for continuation as an analgesic into the immediate post-operative period under the close supervision of medically qualified persons trained in the use of anaesthetic drugs, during transition to longer acting analgesia following adult cardiac surgery,when endotracheal intubation and controlled ventilation are anticipated.,? for provision of analgesia and sedation in mechanically ventilated intensive care patients.

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - cisatracurium besilate, quantity: 0.669 % w/v - solution - excipient ingredients: benzenesulfonic acid; water for injections - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - cisatracurium besilate, quantity: 0.268 % w/v - solution - excipient ingredients: water for injections; benzenesulfonic acid - cisatracurium-aft is indicated for use during surgical and other procedures and in intensive care to relax skeletal muscles, and to facilitate tracheal intubation and mechanical ventilation. it is used as an adjunct to general anaesthesia, or sedation in the intensive care unit.